IBERE PHARMACEUTICALS (IBERWS)
Institutional ownership reported to the SEC as of Q1 2023, across 8 quarters.
1
Reporting holders
$108.1K
Reported value
0.0%
Held as options
-23
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Lynwood Capital Management Inc. | $108.1K | 9,800 | 0.10% | 5q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 1 | $108.1K | 9,800 | 0 | 0 | 0 | 0.0% |
| Q4 2022 | 24 | $2.3M | 2,305,622 | 0 | 1 | 0 | 98.6% |
| Q3 2022 | 37 | $2.7M | 3,906,033 | 3 | 5 | 4 | 86.4% |
| Q2 2022 | 35 | $2.5M | 3,417,368 | 5 | 3 | 3 | 88.0% |
| Q1 2022 | 31 | $2.8M | 3,096,090 | 3 | 2 | 5 | 78.1% |
| Q4 2021 | 28 | $3.8M | 2,947,940 | 6 | 2 | 2 | 58.3% |
| Q3 2021 | 21 | $3.6M | 2,280,010 | 4 | 4 | 0 | 62.4% |
| Q2 2021 | 19 | $3.7M | 1,984,825 | 19 | 0 | 0 | 59.6% |